Skip to main content

Table 6 Adverse events in total patients (N = 152)

From: Microspheres present comparable efficacy and safety profiles compared with polyvinyl alcohol for bronchial artery embolization treatment in hemoptysis patients

Items

PVA group (N = 90)

Microspheres group (N = 62)

P value

Cough/expectoration

29 (32.2)

16 (25.8)

0.394

Fever

4 (4.4)

8 (12.9)

0.071

Chest discomfort

5 (5.6)

3 (4.8)

1.000

Nausea/vomiting

2 (2.2)

0 (0.0)

0.514

Abdominal pain

1 (1.1)

0 (0.0)

1.000

Poor appetite and fatigue

1 (1.1)

0 (0.0)

1.000

Ecchymosis at the puncture site

0 (0.0)

1 (1.6)

0.408

Allergy and dyspnea

1 (1.1)

0 (0.0)

1.000

  1. Comparison was determined by Chi-square test or Fisher’s exact test
  2. PVA polyvinyl alcohol